This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Michael Walter, M.D. (Photo: Business Wire)

Stocks in this article: USMD

Please replace the photos with the accompanying corrected photos.

Michael Walter, M.D. (Photo: Business Wire)

Michael Walter, M.D. (Photo: Business Wire)

The release reads:


USMD Holdings, Inc. ( NASDAQ: USMD), a physician-led integrated health system, announces that USMD Holdings has acquired the assets of Associates in Urology, a Fort Worth-based urology practice group. As a result, Dr. John Pumphrey and Dr. Michael Walter will join USMD’s physician group.

Drs. Pumphrey and Walter bring the total number of USMD urologists to 57, further strengthening USMD’s commitment to caring for and treating patients with urologic conditions across the Dallas-Fort Worth Metroplex. USMD operates one of the largest fully integrated urology groups in the nation. As an integrated group, USMD has the ability to refer patients to other specialists within the group, if needed, who treat a broad spectrum of urologic conditions, including:

  • Prostate cancer, which affects more than 234,000 men nationally each year and is the third leading cause of death among U.S. men.
  • Kidney cancer, which affects nearly 38,000 Americans each year and is the cause of death for nearly 12,000 Americans annually.
  • Bladder cancer, which is the sixth most common cancer across the country—nearly 53,200 Americans are diagnosed with bladder cancer each year.
  • Kidney stones, which are the most common disorder of the urinary tract and account for more than one million visits to health care providers and more than 300,000 emergency room visits nationally each year.
  • Urinary tract infections, which are the second most common infection in the body and account for nearly 7 million visits nationally to health care providers each year.

“I am pleased to welcome Dr. Pumphrey and Dr. Walter to the USMD team,” said John House, M.D., chairman and chief executive officer of USMD Holdings. “USMD is an integrated health system providing services in nearly 20 different specialties. I believe joining the USMD team will provide numerous benefits to current and future patients of Drs. Pumphrey and Walter and it will help ensure that USMD is well positioned to care for the growing needs of patients across the DFW area.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs